Related Experiment Video
Updated: Mar 6, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.1K
Data characterizing the ZMIZ1 molecular phenotype of multiple sclerosis
N Fewings1, P N Gatt1, F C McKay1
1Centre for Immunology and Allergy Research, Westmead Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.
Data in Brief
|March 10, 2017
Summary
This study identifies genes correlated with the autoimmune risk gene ZMIZ1 in multiple sclerosis patients. It reveals metabolic pathways and immune cells involved in this molecular phenotype, offering new insights into disease mechanisms.
Area of Science:
- Immunogenetics
- Neuroimmunology
- Systems Biology
Background:
- Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system.
- The ZMIZ1 gene has been implicated as an autoimmune risk gene in MS.
- Understanding the molecular phenotype associated with ZMIZ1 is crucial for elucidating MS pathogenesis.
Purpose of the Study:
- To identify genes correlated with ZMIZ1 expression across multiple patient cohorts.
- To characterize the phenotypic details of these cohorts.
- To investigate the metabolic pathways and immune cell populations associated with the ZMIZ1 molecular phenotype in MS.
Main Methods:
- Gene correlation analysis across multiple independent cohorts.
- Phenotypic data analysis of patient cohorts.
- Identification of negatively correlated genes and their predominant cell types.
- Over-representation analysis of metabolic pathways.
- Flow cytometry for immune cell identification and ZMIZ1/RPS6 expression analysis.
Main Results:
- A set of genes correlated with ZMIZ1 was identified in multiple sclerosis cohorts.
- Specific metabolic pathways were found to be over-represented among these genes.
- Immune cells predominantly expressing ZMIZ1 and RPS6 were identified using flow cytometry.
- Genes negatively correlated with ZMIZ1 and their cellular sources were characterized.
Conclusions:
- The ZMIZ1 molecular phenotype in multiple sclerosis involves specific gene expression patterns, metabolic pathways, and immune cell populations.
- These findings provide a deeper understanding of the molecular underpinnings of MS.
- Further research into ZMIZ1 and associated pathways may reveal novel therapeutic targets.
